The endoplasmic reticulum (ER) regulates protein synthesis, protein folding, protein trafficking and intracellular Ca 2ϩ . The exposure of stress which interferes with the functions of the endoplasmic reticulum (ER) causes the accumulation of unfolded protein in the ER lumen. 1, 2) Under the these conditions, termed ER stress, a signal transduction pathway, which is called the unfolded protein response (UPR), is activated to increase the expression of ER stress genes such as chaperon protein genes.
.
The exposure of stress which interferes with the functions of the endoplasmic reticulum (ER) causes the accumulation of unfolded protein in the ER lumen. 1, 2) Under the these conditions, termed ER stress, a signal transduction pathway, which is called the unfolded protein response (UPR), is activated to increase the expression of ER stress genes such as chaperon protein genes. 3) This pathway is activated by exposure to ER stressors such as tunicamycin (a glycosylation inhibitor) and thapsigargin, which perturb the calcium in the ER, 4) and so on. The UPR systems such as over-expressions of Bip/GRP78, the inhibition of protein translation via phosphorylation of the a-subunit of translation initiation factor 2 (elF2a) and the activation of ubiquitin-proteasome system usually rescues the cells from any damage by ER-stress. 5) However, prolonged ER stress may finally cause cell death by overcoming the threshold ability of UPR.
Recently, ER stress has received growing attention because ER stress-mediated cell death has been linked to the pathogenesis of several neurodegenerative disorders such as Alzheimer's disease 6, 7) and the obesity connection with type 2 diabetes. 8) Such diseases have also been correlated with the overproduction of various reactive oxygen species (ROS) 9) that are known to induce lipid peroxidation resulting in damage to membranes, proteins and DNA. Recently it has been demonstrated that accumulation of protein within the lumen of the ER causes accunulation of ROS and cell death. 10, 11) Thus anti-oxidative approach might rescue the cells from the disorder via ER stresses.
We have previously synthesized several natural compounds and found that some of them had anti-oxidative or neurotrophic activities. Since it has been suggested that ER disorder is closely linked with neuronal dysfunction, 12) these compounds are anticipated to have specific activities for overcoming ER stresses. Thus, in this manuscript, we screened these compounds on the basis of the neuroprotective effect of tunicamycin-mediated cell damage, which is used as an ER stress model, using IMR32 neuroblastoma cells.
MATERIALS AND METHOD

Materials
Magnolol and Honokiol (neurotrophic compound) 13) were obtained from Wako pure Chem. Ltd. (Osaka, Japan). Talaumidin (neurotrophic compound) was isolated from Aristolochia arcuata Masters.
14) Norbergenin-11-caproate (NB-11-cap, antioxidant), 15) four Ardisiaquinone derivatives (5-lipoxygenase inhibitors) 16) and Toosendanin (a cytotoxic compound) 17) were chemically synthesized as described. Their chemical structures are shown in Fig. 1 MTT Assay IMR32 cells detached from tissue culture dishes were seeded in a well of a 96-well flat-bottomed tissue culture plate at a density of 5ϫ10 3 cells/well in standard medium and cultured at 37°C for over 24 h to adhere. After discarding the supernatant, if needed, cells were pretreated with new medium containing chemicals for 30 min, and were subsequently mixed with tunicamycin (DMSO solution) in quadruplicate to achieve a final volume of 100 ml and then cultured for 24 h or 48 h. The final concentration of DMSO in the culture was within 0.5%. Cells were then mixed with MTT at a final concentration of 0.5 mg/ml and incubated at 37°C for 4 h. Sodium dodecyl sulfate solution (10% w/v, 100 ml) was added into each well and the plate was then incubated at room temperature overnight under dark conditions. The absorbance of the mixture was measured at 570 nm using a microplate spectrophotometer. The percentages of the absorbance from the sample-treated cells as compared with the non-treated control were calculated. DMSO alone (0.5%) showed no effect in all analyses.
RT-PCR Analysis IMR32 cells adhered on a plastic dish at a density of 5ϫ10 4 cells/cm 2 were pretreated with or without NB-11-cap for 30 min, then added with tunicamycin and cultured for 6 h. Cells were harvested by pipetting and the total RNA was isolated using Trizol reagent (Gibco BRL, Gaithersberg, MD, U.S.A.). Reverse transcription-polymerase chain reaction (RT-PCR) was performed using an Access RT-PCR kit (Promega, Madoson, WI, U.S.A.) according to the manufacturer's procedure. The sequences of the primers used for amplification are as follows: human Bip/GRP78 primer, sense, 5Ј-GAT-AAT-CAA-CCA-ACT-GTT-AC-3Ј; antisense, 5Ј-GTA-TCC-TCT-TCA-CCA-GTT-GG-3Ј; GAPDH primer, sense, 5Ј-CCA-TGG-AGA-AGG-CTG-GGG-3Ј; antisense, 5Ј-CAA-AGT-GTC-ATG-GAT-GAC-C-3Ј.
Measurement of the Reactive Oxygen Species (ROS) in Single Cell
Analysis by Flow Cytometry IMR32 cells in sub-confluent culture (5ϫ10 4 cells/cm 2 ) adhered on petridishes were pretreated with or without NB-11-cap for 30 min, subsequently mixed with tunicamycin and cultured for 2.5 h in a humidified CO 2 incubator, and then loaded with DCFHDA at a final concentration of 20 mM. After the more 30 min incubation, cells were harvested by pipetting followed by washing with ice-cold PBS twice. The cell fluorescence from intracellular DCF (as ROS signals) was measured at PMT2 detector using an ELITE flow cytometer (EPICS). Ten thousand counting events were recorded and the mean fluorescence intensities were calculated for each sample.
RESULTS
Effect of Tunicamycin on the Viability of IMR32 Cells
When IMR32 cells were treated with tunicamycin, the viability of IMR32 cells determined by MTT method was decreased in a dose-dependent manner as shown in Fig. 2 . The 50% inhibitory concentration (IC 50 ) in the case of 48-h exposure was about 0.2 mg/ml, whereas in the case of 24-h exposure, it was not detected within 2.5 mM. Thus the longer exposure to tunicamycin resulted in the higher inhibition of the viability. However, even at the highest concentration of tunicamycin (2.5 mM), the rate of inhibition was not complete (about 60% inhibition). The morphology of a part of the cells treated with tunicamycin at 2.5 mg/ml for 48 h seemed to be necrotic as characterized by balloon-up feature and another part showed apparent integrity. Trypan blue dye exclusion method also showed that only 16% of the cells were dead from necrosis. However the total cell numbers after the 48 htreatments of tunicamycin (0.1, 1mM) were 4.3 and 3.1ϫ10 5 cells/well (1.20 and 0.88 fold of the initial), respectively, while that of non-treated control was 8.9ϫ10 5 /well (2.67 fold). Thus hereafter, this decrease of viability is termed the cell growth inhibitory effect.
Screening of Chemical Compounds in Anti-tunicamycin Activity Next, nine compounds, which are known to have pro-or anti-neuronal functions, were examined for protective effects from the tunicamycin-induced cell growth inhibitory effect in IMR-32 cells by colorimetric MTT assay. The results from only four representative compounds are shown in Fig. 3a . NB-11-cap diminished the effect of tunicamycin in a dose-dependent manner, reaching complete inhibition at 10 mg/ml. Toosendanin showed an enhanced cell growth inhibitory effect as compared with tunicamycin alone, as it has been shown that Toosendanin has direct cytotoxicity (data not shown). Both Magnolol and Ardisiaquinon A showed no additive effect in the cell growth inhibitory effect even at the highest doses tested (10 mM). The other five compounds listed in Fig. 1 also showed no effect (data not shown). Concerning the antioxidant activity of NB-11-cap, a well-known antioxidant a-tocopherol was tested as in Fig.  3b . It inhibited the effect of tunicamycin, but only partial (80% of control) inhibition was exhibited even at 100 mM ( Fig. 3b) .
Effect of NB-11-Cap on the Bip/GRP78 mRNA Expression via Tunicamycin When IMR32 cells were treated with tunicmycin (0.1 mM), the expression level of Bip/GRP78 mRNA began to increase at 3 h, and reached a plateau at 6 h (data not shown), which was about 5 times the control level (Fig. 4) . It is noteworthy that this augmentation of Bip/GRP78 mRNA by tunicamycin was not inhibited by the pretreatment with 10 mM NB-11-cap (Fig. 4) .
Effect of NB-11-Cap on the ROS Production via Tunicamycin In concerning with the ROS overproduction via ER stress, the intracellular ROS level after tunicamycin treatment was evaluated with or without NB-11-cap pretreatment. In order to evaluate the early phase events, the intracellular ROS levels after 3-h exposure to tunicamycin was detected. Since 0.1 mM tunicamycin resulted in only slight ROS augmentation (data not shown), here the experimental condition with 0.3 mM tunicamycin was selected in order to estimate significant anti-ROS effect of NB-11-cap. As shown in Fig.  5 , the intracellular ROS level was significantly augmented by the 3 h incubation with 0.3 mM tunicamycin by 64%, and this ROS elevation was compensated with both 10 mM NB-11-cap and 100 mM a-tocopherol. These phenomena were almost the same in the cases of 6-h exposure to tunicamycin (data not shown).
DISCUSSION
We have investigated the ability of several compounds to provide neuroprotective activity against the tunicamycin-induced ER stresses using undifferentiated neuroblasoma cell line IMR32 cells as a neuron cell model. In the present study, only NB-11-cap among the compounds investigated showed the anti-tunicamycin effect.
Norbergenine is the main component of Mallotus japonicus and has been used as a traditional drug for treatment of hyperacid and stomach ulcers. We have previously found that Norbergenine and its derivatives exhibited strong antioxidant activity in vitro and that some of them also actually prevented rat cortical neuronal cells from spontaneous death in primary culture. As shown in Fig. 2 , the cell growth inhibitory effect of tunicamycin was greater in 48-h than in 24-h exposure. This kinetic change might show that the level of growth-inhibitory products (signal) accumulated by ER stress was relatively low in 24-h exposure, being compensated by the cellular UPR. In the case of 48-h exposure, such damage might accumulate more and overcome the UPR capacity, resulting in significant cell growth inhibition or cell death.
NB-11-cap inhibited the cell growth inhibitory effect of tunicamycin, but it did not inhibit Bip/GRP78 mRNA induction (Fig. 4) . This means that NB-11-cap protected not the initial function of tunicamycin such as the inhibition of Nlinked glycosylation but a later function for cell growth. It is known that ER stress leads to caspase-12-dependent apoptosis. 18, 19) However no apparent evidence for apoptotic cell death was observed in the tunicamycin-treated IMR32 cells (data not shown). As has been demonstrated, 10, 11) we hypothesized that the accumulated cell damage via tunicamycin might be the overproduction of ROS. As shown in Fig. 5 , tunicamycin actually augmented the intracellular ROS level and this ROS production was inhibited by both NB-11-cap and an anti-oxidant, a-tocopherol. NB-11-cap compensated completely the cell growth inhibitory effect of tunicamycin (Fig. 3a) , but in contrast, a-tocopherol did so only in part (Fig. 3b) . These findings suggest that the effect of tunicamycin is mediated by ROS, at least in part, and that the protective activity of NB-11-cap may be caused not only by anti-oxidative activity but also the other (unknown) activities.
Taken together, it is demonstrated in this manuscript that a natural compound derivative, NB-11-cap, has a potential to scavenge ER stress-inducing cell damage. The application of NB-11-cap for ER-stress dependent diseases is anticipated.
